What is Eikon Therapeutics, Inc. 's operating cash flow?

Eikon Therapeutics, Inc. (EIKN) reported operating cash flow of -$89.8M in Q1 2026.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

MYR GroupMYRG

$84.75M+1.8%

Dave, Inc.DAVE

$82.03M+81.3%

Piper SandlerPIPR

-$291.72M-40.8%

SSR MiningSSRM

$264.49M+221%

NNN REITNNN

$187.03M-8.0%

RepligenRGEN

$28.3M+88.6%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's operating cash flow?: Eikon Therapeutics, Inc. (EIKN) reported operating cash flow of -$89.8M in Q1 2026.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.